Literature DB >> 19268442

Expression of nestin mRNA is a differentiation marker in thyroid tumors.

Hiroya Yamada1, Toru Takano, Yasuhiro Ito, Fumio Matsuzuka, Akihiro Miya, Kaoru Kobayashi, Hiroshi Yoshida, Mikio Watanabe, Yoshinori Iwatani, Akira Miyauchi.   

Abstract

Nestin is a maker that identifies stem cells in some adult tissues, and its expression is believed to relate to malignancy in cancer cells. In this study, we measured the expression levels of nestin mRNA in various kinds of thyroid tumor by the real-time quantitative reverse transcription-polymerase chain reaction. Unexpectedly, nestin mRNA was detected in almost all differentiated thyroid tumors and normal thyroid tissues, whereas extremely decreased expression was observed in anaplastic carcinomas, which are the most malignant of the thyroid follicular cell-derived tumors. These results suggest that nestin mRNA is a differentiation marker, and its expression does not relate to malignant characteristics in thyroid tumors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19268442     DOI: 10.1016/j.canlet.2009.02.006

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

Review 1.  Nestin in gastrointestinal and other cancers: effects on cells and tumor angiogenesis.

Authors:  Toshiyuki Ishiwata; Yoko Matsuda; Zenya Naito
Journal:  World J Gastroenterol       Date:  2011-01-28       Impact factor: 5.742

Review 2.  Thyroid stem cells--danger or resource?

Authors:  B Gibelli; Ama El-Fattah; G Giugliano; M Proh; E Grosso
Journal:  Acta Otorhinolaryngol Ital       Date:  2009-12       Impact factor: 2.124

Review 3.  Nestin and other putative cancer stem cell markers in pancreatic cancer.

Authors:  Yoko Matsuda; Shoko Kure; Toshiyuki Ishiwata
Journal:  Med Mol Morphol       Date:  2012-06-21       Impact factor: 2.309

4.  Immunohistochemical detection of epithelialmesenchymal transition associated with stemness phenotype in anaplastic thyroid carcinoma.

Authors:  Jing Liu; Robert E Brown
Journal:  Int J Clin Exp Pathol       Date:  2010-10-01

5.  Expression of cancer stem cell markers and epithelial-mesenchymal transition-related factors in anaplastic thyroid carcinoma.

Authors:  Chang Won Jung; Kang Hee Han; Hyesil Seol; Sunhoo Park; Jae Soo Koh; Seung-Sook Lee; Min Joo Kim; Ik Joon Choi; Jae Kyung Myung
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

6.  Knockdown of Nestin inhibits proliferation and migration of colorectal cancer cells.

Authors:  Jing Li; Rui Wang; Lei Yang; Qi Wu; Qinwan Wang; Zhengchao Nie; Yongchun Yu; Ji Ma; Qiuhui Pan
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

7.  The transcription factor Olig2 is important for the biology of diffuse intrinsic pontine gliomas.

Authors:  Jane L Anderson; Ranjithmenon Muraleedharan; Nicole Oatman; Amanda Klotter; Satarupa Sengupta; Ronald R Waclaw; Jianqiang Wu; Rachid Drissi; Lili Miles; Eric H Raabe; Matthew L Weirauch; Maryam Fouladi; Lionel M Chow; Lindsey Hoffman; Mariko DeWire; Biplab Dasgupta
Journal:  Neuro Oncol       Date:  2017-08-01       Impact factor: 12.300

8.  Transcriptional activity of the 5'-flanking region of the thyroid transcription factor-1 gene in human thyroid cell lines.

Authors:  Hiroya Yamada; Toru Takano; Fumio Matsuzuka; Mikio Watanabe; Akira Miyauchi; Yoshinori Iwatani
Journal:  Genet Mol Biol       Date:  2011-03-01       Impact factor: 1.771

9.  Expression and role of nestin in human cervical intraepithelial neoplasia and cervical cancer.

Authors:  Atsuki Sato; Toshiyuki Ishiwata; Yoko Matsuda; Tetsushi Yamamoto; Hirobumi Asakura; Toshiyuki Takeshita; Zenya Naito
Journal:  Int J Oncol       Date:  2012-05-10       Impact factor: 5.650

10.  Production of Monoclonal Antibody against Human Nestin.

Authors:  Reza Hadavi; Amir Hassan Zarnani; Negah Ahmadvand; Ahmad Reza Mahmoudi; Ali Ahmad Bayat; Jafar Mahmoudian; Mohammad-Reza Sadeghi; Haleh Soltanghoraee; Mohammad Mehdi Akhondi; Majid Tarahomi; Mahmood Jeddi-Tehrani; Hodjattallah Rabbani
Journal:  Avicenna J Med Biotechnol       Date:  2010-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.